510(k) Report

510(k) · Cleared

Cleared

Cryo Check Factor V Deficient Plasma

K971223510(k) TraditionalCleared Jul 22, 1997111-day reviewClass II21 CFR 864.7290

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Precision Biologicals, Inc. · GJT Plasma, Coagulation Factor Deficient

Cleared on Jul 22, 1997 after a 111-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Jul 22, 1997
Review
111 days
Class
Class II
Product code
GJT
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K971223Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GJT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GJT device

  1. #1 K222831 CRYOcheck Factor VIII Deficient Plasma with VWFscore 6.6 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GJT devices

GJT Plasma, Coagulation Factor Deficient: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GJT

1in 2023

2011: 32018: 12023: 1
2007high 3 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GJT

444in 2011

2011: 444 days median
2007high 444 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GJT

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GJT

1in 2025

2013: 32017: 12018: 62020: 12024: 22025: 1
2007high 6 (2018) · low 0 (2007)2025

MAUDE reports naming product code GJT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
2011344400
20120—00
20130—13
20140—00
20150—00
20160—00
20170—01
20181—06
20190—00
20200—01
20210—00
20220—00
20231—00
20240—02
20250—01
20260—0—

What is it indicated for?

Deficiencies in coagulation factors may have congenital or acquired etiologies and can compromise in vivo hemostasis. Factor V is a single chain glycoprotein with a molecular weight of 330,000 and is important for both intrinsic and extrinsic coagulation. Factor V deficiency is commonly diagnosed in vitro through the used of a modified prothrombin time (PT) assay. When a patient sample is mixed with factor V deficient plasma, the degree of correction of…

Read the full statement (133 words)

Deficiencies in coagulation factors may have congenital or acquired etiologies and can compromise in vivo hemostasis. Factor V is a single chain glycoprotein with a molecular weight of 330,000 and is important for both intrinsic and extrinsic coagulation. Factor V deficiency is commonly diagnosed in vitro through the used of a modified prothrombin time (PT) assay. When a patient sample is mixed with factor V deficient plasma, the degree of correction of the PT is proportional to the level of Factor V in the patient plasma.

CryoCheck Factor V Deficient Plasma is human plasma deficient in the factor V coagulation protein while having all other coagulation factors within normal limits. It is indicated for use to assess factor V deficiencies in in vitro clot-based factor V assays using the one stage prothrombin time.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971223: Cryo Check Factor V Deficient Plasma.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K971223

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026